Royalty Report: Medical, Device, Surgical – Collection: 368481

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 11

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 11

Primary Industries

  • Medical
  • Device
  • Surgical
  • Tissue
  • Diagnostic
  • Therapeutic
  • Ophthalmological
  • Cancer
  • cardiac
  • Delivery
  • Instruments
  • Test/Monitoring
  • Ultrasound
  • Catheter

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 368481

License Grant
Licensor grants a non-transferable non-assignable, non-exclusive worldwide license, without the right to sublicense, under the Licensed Patent Rights to make, have made, market, use, import, distribute, sell, have sold, and offer for sale the Licensed Products solely in the Field of Use.

For the Option, Licensor grants an option for a non-transferable, non-assignable, non-exclusive license, without the right to sublicense, under the Licensed Patent Rights to make , have made, market, use, import, distribute, sell, have sold and offer for sale Licensed Products solely in one or more of the Additional Fields.

License Property
Licensed Products shall mean a Controller or Disposable Product within the scope of a Valid Claim, which is either an aparatus or method claim.

Controllers shall mean a radio frequency power supply that operates at any frequency between 10Khz and 20Mhz.

Disposable Products shall mean medical instruments and components of such medical instruments which may have one or more electrode(s) and electrical connections for coupling the electrode(s) to a Controllers.

Lumen Products shall mean Disposable Products having one or more lumens for the purpose of aspiration or fluid delivery.

Thermal Products shall mean Disposable Products used for the thermal treatment of tissue without significantly ablating, cutting, resecting or otherwise removing tissue.

The rights relate  to Licensor's Coblation radiofrequency technology for use in its single electrode, bipolar arthroscopic surgical devices.

Field of Use
The Field of Use  shall mean the use of RF energy in arthroscopy.

Additional Fields shall mean the use of RF energy in laparoscopy, neurosurgery, general surgery, ENT and spinal procedures.

The Coblation technique uses bipolar radiofrequency technology to remove tissue with minimal collateral tissue necrosis.

IPSCIO Record ID: 245918

License Grant
License Grant to Licensee under the Licensor Infusion Claims. Subject to the terms and conditions of this Agreement, including, without limitation, the limitations set forth in this agreement, and in consideration of the payment of royalties by Licensee to Licensor, Licensor hereby grants to Licensee and Licensee’s Affiliates, under the Licensor Infusion Claims, a non-exclusive license throughout the Licensed Territories in the Field to make, have made, use, practice, import, offer to sell, sell and otherwise dispose of or make available for use, directly or indirectly, Products and Methods which, but for the license granted herein, would infringe any one or more of the Licensor Infusion Claims. Notwithstanding any other provision of this Agreement
(a) the foregoing license extends only to such Products and Methods as are offered for sale, sold and otherwise disposed of or made available for use under Licensee’s (or its Affiliates’) own trademarks, tradenames and/or label(s), which shall be the most prominent trademarks, tradenames and/or label(s) thereon, and does not extend, and shall not be construed to extend, to any Products, or parts or components thereof, offered for sale, sold or otherwise disposed of or made available for use to any Third Person by Licensee or its Affiliates for resale or re-distribution by such Third Person solely under such Third Person’s own trademarks, tradenames and/or label(s); and
(b) Licensee, on behalf of itself and its Affiliates, hereby covenants and agrees not to market, offer for sale or sell any Products or Methods that, absent the foregoing license, would infringe the Licensor Infusion Claims, until eighteen (18) months after the Effective Date.
License Property
Licensor Infusion Claims shall mean those Claims of any patents within the Licensor Patent Portfolio which require for infringement liquid infusion capability or the use of liquid infusion.

Licensor Patent Portfolio
U.S. Patent No. 5,458,597 – Device for treating cancer and non-malignant tumors and methods
U.S. Patent No. 5,472,441 – Device for treating cancer and non-malignant tumors and methods
U.S. Patent No. 5,486,161 – Medical probe device and method

Field of Use
Field shall mean Products and Methods used to ablate tumors with radio frequency (RF) electrical energy.  Sub-Field shall mean tumor ablation within the Field directed to specific organs or regions of the body.

IPSCIO Record ID: 163887

License Grant
Assignor sells, assigns, conveys, transfers and delivers to Assignee, its successors and permitted assigns, the Spot Catheter Patents and the Spot Catheter Technology and the Linear Catheter Patents and the Linear Catheter Technology to be used only in the Field of Use.
License Property
Assignor is in the business of developing implantable cardiac defibrillators and electrophysiology catheters. The IP includes patents and U.S. Patent Applications, Serial Nos. 08/496,947 and 09/073,651 and corresponding foreign patents.
Field of Use
The Field of Use shall mean the radio frequency (RF) cardiac ablation therapy field.  This agreement pertains to the medical industry.

IPSCIO Record ID: 98161

License Grant
Licensor hereby grants Licensee an exclusive license to make, have made, use and sell Licensed Product anywhere in the Territory.

Licensors grant a non-exclusive license to Licensee to use Licensed Trademarks in connection with medical/surgical instruments, tissue aspiration and aspirators for use in liposuction. Licensors represent they will not manufacture, sell, distribute or issue another license of Licensed Trademarks for manufacture, sale, or distribution of medical/surgical instruments, tissue aspiration and/or aspirators for use in liposuction as granted Licensee so long as Licensee is otherwise in compliance with this Modified License Agreement.  Licensor explicitly retains an unrestricted right to use trademarks to indicate the use of such branded instruments in one or more surgical centers and to sell or distribute products manufactured by and purchased from Licensee in those centers to other physicians at demonstrations or seminars.

Part of the modifications address a change in the royalty rate.

License Property
Licensed Product. Licensed Product shall mean a product made, sold or used for liposuction and covered by one (1) or more valid claims of the Licensed Patents relating to the liposuction field of use.

Licensors are the exclusive owner of all right, title and interest in and to the allowed U.S. Trademarks Airbrush (2,915,009), Airbrush Liposculpture (2,972,590), and Airbrush & Design (2,978,135), (hereinafter Licensed Trademarks) in connection with medical/surgical instruments, tissue aspiration and aspirators.

Licensors are the exclusive owner of all right, title, and interest in and to issued U.S. Patent Nos. 5,112,302, 5,348,535, 5,643,198, 5,795,323, 6,346,107, 6,394,973, 6,761,701, 6,6,652, 522, 6,8,72,199, 7,112,200 B2, 7,381,206 B2, 7,384,417, and the following pending U.S. Patent Applications 11/081,885, 11/145,027, 11/552,799, 11/981,206 B2, and European Patent Organization Application 94306845.2 and any reissues thereof (hereinafter Licensed Patents).

Field of Use
This agreement pertains to the medical industry relating to the liposuction field of use in connection with medical/surgical instruments, tissue aspiration and aspirators.

IPSCIO Record ID: 26776

License Grant
COMPANY hereby grants and LICENSEE hereby accepts a license under the Licensed Patents to make, use, and sell Licensed Products for use in the Licensed Field of Use within the Licensed Territory.  An exclusive worldwide license is granted for technology applicable in medical and surgical fields related to ophthalmological applications.
License Property
DESCRIPTION                          PATENT #               ISSUED

SURGICAL LIQUID LANCE APPARATUS*              5,037,431            AUG 6, 1991

METHOD AND APPARATUS FOR TISSUE               5,322,504            JUN 21, 1994

EXCISION AND REMOVAL BY FLUID JET**

FLUID JET SURGICAL CUTTING INSTRUMENT         5,591,184            JAN 7, 1997

METHOD AND APPARATUS FOR TISSUE               5,674,226            OCT 7, 1997

EXCISION AND REMOVAL BY FLUID JET

FLUID JET SURGICAL CUTTING TOOL               5,562,692            OCT 8, 1996

HYDROJET APPARATUS FOR REFRACTIVE             5,643,299            JUL 1, 1997

SURGERY

METHOD OF USING FLUID JET SURGICAL            5,735,815            APR 7, 1998

CUTTING TOOL

METHOD AND APPARATUS FOR THERMAL            08/755,622            AUG 4, 1998

PHOCOEMUSIFICATION BY FLUID THROTTLING

METHOD AND APPRATUS FOR DENTAL              08/890,496           SEPT 28, 1998

TREATMENT USING HIGH PRESSURE LIQUID
JET

Field of Use
'Licensed Field of Use' means the medical and surgical fields  related to ophthalmological applications.

IPSCIO Record ID: 1098

License Grant
Licensor grants Licensee a non-exclusive, world-wide license under the Licensed Patents to the Licensed Devices for Licensed Applications which would infringe any valid claim of the Licensed Patents.
License Property
Licensor is the owner of U.S. Patent No. 5,037,421 and U.S. Patent No. 5,147,354 both entitled 'Mid Infrared Laser Arthroscopic Procedure'.

LICENSED DELIVERY DEVICE shall mean any device that delivers the laser energy to a desired location which infringes one or more of the valid claims of the Licensed Patents.

Field of Use
LICENSED APPLICATION shall mean only orthopedic applications.

IPSCIO Record ID: 29254

License Grant
The Licensor granted the Licensee an exclusive license (including the right to grant sublicenses) in and to the devices and the technology for the purposes of making, having made, using and selling the Devices.
License Property
The devices relate to ophthalmic applications of fluid jet technology.
Field of Use
Licensed Field of Use means the medical and surgical fields related to ophthalmological applications.

IPSCIO Record ID: 645

License Grant
Licensor hereby grants to Licensee (a) a royalty-bearing, and exclusive license under the Subject Technology to make, have made, use and sell Wet Electrode Products in the Field of Use that are Licensed Products throughout the Territory and (b) a royalty-bearing and non-exclusive license under the Subject Technology to make, have made, use and sell Wet Electrode Generators in the Field of Use that are Licensed Products throughout the Territory.
License Property
Licensor has developed certain technology related to “Wet Electrode Products” and a “Wet Electrode Generator”.

“Wet Electrode Generator(s)” shall mean the medical generators primarily intended to provide power directly to Wet Electrode Products, in the Field of Use.

“Wet Electrode Products” shall mean medical blades, forceps or rollerballs that employ an electrode to deliver radio frequency energy and an electrically conductive fluid between the electrode and the surface of living tissue to apply radio frequency energy in medical applications, in the Field of Use. Wet Electrode Products specifically exclude any interstitial needle or intraluminal wire devices or products.

The technology forms the basis for the Company’s TranscollationTM technology.

Transcollationâ„¢ is the transformation of fibrous collagen resulting from the remodeling of its triple helix structure.  Transcollationâ„¢ Technology simultaneously integrates saline and RF energy allowing thermal energy to gently reach targeted tissues via saline-induced liquid electrodes.

Transcollation technology platform is used for the sealing of blood vessels and other collagen-based structures. We believe that our products improve surgical procedures and patient outcomes by enabling surgeons to substantially reduce blood loss during and after surgery. We believe our Transcollation technology provides clinical and economic benefits to patients, physicians, hospitals and payors by addressing many of the limitations of alternative blood loss management methods. Our Transcollation technology is designed to deliver an optimized combination of RF energy and electrically conductive fluid, such as saline, to permanently seal blood vessels and other collagen-based structures in soft-tissue and bone.

Interstitial Needle Patents

IPSCIO Record ID: 203978

License Grant
The Canadian Licensor grants to Licensee an exclusive, worldwide license, with the right to grant and authorize sublicenses, to Licensors entire interest in and to the Licensed Patents within the Field to make, have made, use, import, have imported, sell, offer for sale and otherwise exploit and distribute Licensed Products within the Field, and practice any method, process or procedure included within the Licensed Patents in the Field.
License Property
The licensed patents are for Two-Dimensional and Three-Dimensional Digital Ultrasound Tracking Systems for surgery.  The Licensed Product means a product within the scope of one or more Valid Claims of the Licensed Patents in the country of manufacture or sale;  produced, processed or otherwise manufactured by a process or method within the scope of one or more Valid Claims of the Licensed Patents in the country of such manufacture; or; used in a process and/or method within the scope of one or more Valid Claims of the Licensed Patents in the country where such product is made or sold.
Field of Use
The Field shall mean use of any medical device and procedure applications in and on the heart that utilize essentially real-time triangulation algorithms to determine the three-dimensional position of transducers, excluding procedures solely and directly related to heart valve surgery.

IPSCIO Record ID: 369243

License Grant
For the CoSeal Sealant Units Exclusive Distribution, Sales and Marketing Rights,  Licensors of the United States, Switzerland and Canada grant
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in the Sealant Territory; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in the Sealant Territory during the term of this Distribution and License Agreement.

For the CoSeal Sealant Option, Licensor grants an option (the CoSeal Sealant Option)
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in Japan; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Sealant Units in Japan.

For the CoSeal Adhesion Prevention Units Exclusive Distribution, Sales and Marketing Rights, Licensor grants
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the Adhesion Prevention Territory; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the Adhesion Prevention Territory during the term of this Distribution and License Agreement.

For the CoSeal Adhesion Prevention Option, Licensor grants to an option (the CoSeal Adhesion Prevention Option)
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the United States; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Adhesion Prevention Units in the United States.

For the CoSeal Accessories Exclusive Rights, Licensor grants
— a sole and exclusive license, with right to sublicense, under Licensor Patents and Trademarks to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import CoSeal Accessories in the Field in the Territory; and
— a non-exclusive license, with right to sublicense, under Licensor Know-How to use, have used, market, have marketed, distribute, have distributed, sell, have sold, offer for sale, export and import the CoSeal Accessories in the Field in the Territory.

License Property
The trademarks include COSEAL©, ADHIBIT™, and, ANGIOTECHKNOWLEDGY™.

CoSeal Ingredients shall mean the two derivatized polyethylene glycol ingredients, designated COH102 and COH206

CoSeal Adhesion Prevention Unit shall mean a CoSeal Adhesion Prevention Product sold in combination with a CoSeal Adhesion Prevention Device.

CoSeal Devices shall mean, collectively, as the context requires, both or either of the CoSeal Adhesion Prevention Devices and/or the CoSeal Sealant Devices.

CoSeal Unit shall mean, collectively, as the context requires, both or either of the CoSeal Sealant Unit and/or the CoSeal Adhesion Prevention Unit.

CoSeal Sealant Unit shall mean a CoSeal Sealant Product sold in combination with a CoSeal Sealant Device.

CoSeal Sealant Product shall mean a product containing the CoSeal Ingredients that is the subject matter of a Regulatory Filing for use as a tissue sealant, adhesive or glue, has been or is approved by one or more Regulatory Authorities for use as a tissue sealant, adhesive or glue, or that is in development or sold for use as a tissue sealant, adhesive or glue.

Field of Use
CoSeal is indicated for use in vascular reconstructions to achieve adjunctive ·hemostasis by mechanically sealing areas of leakage.  CoSeal is designed to rapidly seal tissue surfaces, suture lines and synthetic grafts during surgery.

Field shall mean human therapeutic use for any and all tissue sealing, adhesive, glue or adhesion prevention barrier indications but shall specifically exclude any use (i) in Hemostat indications; (ii) for tissue regeneration indications; (iii) as an osteobiologic for skeletal repair an non-pharmacologic devices for osteoarthritis treatment,; (iv) as a urinary incontinence product and for the treatment of urinary incontinence; or (v) as an ostomy product.

IPSCIO Record ID: 283410

License Grant
The Licensor, a nonprofit American academic medical center,  grants to Company the following (a) an exclusive license with the right to sublicense, within the Field and Territory, under the Patent Rights to make, have made, use, offer for sale, sell, and import Licensed Products; and (b) a nonexclusive license, with the right to sublicense, within the Field and Territory, to use the Know-How to develop, make, have made, use, offer for sale, sell, and import Licensed Products.
License Property
Patent Rights shall mean U.S. patent number 8,538,501, and any re-examinations and re-issues thereof, as well as extensions and supplementary protection certificates and any foreign counterpart of any of the foregoing.

8,538,501 – Mapping and ablation catheter system

Licensed Product shall mean any product, process, or service which (a) the manufacture, use, sale, offer for sale or importation of which infringes an issued claim of the Patent Rights, or that would infringe but for the exception in 35 U.S.C. §271(e)(1), or similar exception in the United States or other countries; or (b) the development, manufacture, use, sale, offer for sale or importation of which incorporates, uses, was derived from, identified by, validated, or developed in whole or in part using the Know-How.

Field of Use
Field shall mean a mapping and ablation catheter system.
Pure EP is a computerized system designed to acquire, digitize, measure, display and store electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures.
The product sets out to assist electrophysiologists with decision-making during EP procedures in patients with abnormal heart rates and rhythms.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.